Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
D000328:Adult; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D008713:Methimazole / Q000627:therapeutic use; D008779:Methylthiouracil / Q000009:adverse effects* / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D011863:Radioimmunoassay; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood*
D014284:Triiodothyronine; D008713:Methimazole; D011441:Propylthiouracil; D013974:Thyroxine; D008779:Methylthiouracil